Chemours Company (The) (NYSE:CC) stock is expected to deviate a maximum of $2.75 from the average target price of $11.75 for the short term period. 4 Street Experts have initiated coverage on the stock with the most promising target being $15 and the most muted being $9.
The Chemours Company has lost 15.49% in the last five trading days and dropped 6.36% in the last 4 weeks. The Chemours Company is up 10.94% in the last 3-month period. Year-to-Date the stock performance stands at 54.97%. Also, Major Brokerage house, Citigroup maintains its ratings on Chemours Company (The) (NYSE:CC). In the latest research report, Citigroup raises the target price from $5 per share to $8 per share. According to the latest information available, the shares are now rated Neutral by the analysts at the agency. The rating by the firm was issued on April 18, 2016.
Chemours Company (The) (NYSE:CC) : The consensus on Chemours Company (The) (NYSE:CC) based on 5 analyst recommendation on the company stock is 3, which is interpreted as a Hold recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 1 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 3 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating. 1 analyst sees the stock overvalued at current levels and advises a Strong Sell on the stock.
Chemours Company (The) (NYSE:CC): The stock opened at $8.44 on Thursday but the bulls could not build on the opening and the stock topped out at $8.51 for the day. The stock traded down to $8.13 during the day, due to lack of any buying support eventually closed down at $8.24 with a loss of -2.72% for the day. The stock had closed at $8.47 on the previous day. The total traded volume was 5,088,375 shares.
In an insider trading activity, Newman Mark, CFO of Chemours Co, executed a transaction worth $27,160 on May 13, 2016. A total of 2,800 shares were purchased at an average price of $9.7. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.
The Chemours Company (Chemours) is a provider of performance chemicals. The Company delivers solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, general industrial, and mining and oil refining. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2) under the brands, including Ti-Pure and Vantage. Its Fluoroproducts segment is a provider of fluoroproducts under the brands, including Suva, ISCEON, Freon, Opteon, Teflon, Tefzel, Viton, Krytox, Formacel, Dymel, FM 200, Nafion and Capstone. Its Chemical Solutions segment is a provider of industrial and specialty performance chemicals under the brands, including Virkon and Oxone. The Companys products include titanium dioxide, refrigerants, industrial fluoropolymer resins, sodium cyanide, sulfuric acid and aniline.